Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Morrey

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Antiviral Research|January 1, 1991
Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infectionJ D Morrey, R P Warren, K M Okleberry, et al.
Biotechnology Therapeutics|January 1, 1993
Effect of immunomodulators in the hu-PBL-SCID mouse modelJ R Mead, R A Burger, J D Morrey, et al.
Antiviral Research|March 1, 1992
Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) miceJ D Morrey, J R Mead, R P Warren, et al.
Acta Virologica|February 15, 2000
Resistance to Friend leukemia virus in transgenic mice expressing the native Fv-4 geneM K Jackson, E A Mitchell, S G Winslow, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infectionJ D Morrey, R P Warren, K M Okleberry, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201R W Sidwell, D F Smee, J H Huffman, et al.
Journal of Virology|September 1, 1991
In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic miceJ D Morrey, S M Bourn, T D Bunch, et al.
Antiviral Research|July 13, 2001
Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201R W Sidwell, D F Smee, J H Huffman, et al.
Journal of Viral Hepatitis|November 15, 2002
Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNAD V Morrissey, P A Lee, D A Johnson, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Antiviral Research|January 1, 1991
Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infectionJ D Morrey, R P Warren, K M Okleberry, et al.
Biotechnology Therapeutics|January 1, 1993
Effect of immunomodulators in the hu-PBL-SCID mouse modelJ R Mead, R A Burger, J D Morrey, et al.
Antiviral Research|March 1, 1992
Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) miceJ D Morrey, J R Mead, R P Warren, et al.
Acta Virologica|February 15, 2000
Resistance to Friend leukemia virus in transgenic mice expressing the native Fv-4 geneM K Jackson, E A Mitchell, S G Winslow, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infectionJ D Morrey, R P Warren, K M Okleberry, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201R W Sidwell, D F Smee, J H Huffman, et al.
Journal of Virology|September 1, 1991
In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic miceJ D Morrey, S M Bourn, T D Bunch, et al.
Antiviral Research|July 13, 2001
Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201R W Sidwell, D F Smee, J H Huffman, et al.
Journal of Viral Hepatitis|November 15, 2002
Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNAD V Morrissey, P A Lee, D A Johnson, et al.
Pageof 3